Loading…
Impact of chronic obstructive pulmonary disease on the outcome of patients admitted to the coronary care unit
Background The prevalence of chronic obstructive pulmonary disease (COPD) varies between countries and age groups but is estimated to be between 15 and 20% in the European adult populations over 40 years. COPD is accompanied with increased risk of multiple, chronic comorbidities. One of those chroni...
Saved in:
Published in: | The Egyptian journal of chest diseases and tuberculosis 2019-04, Vol.68 (2), p.123-128 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background The prevalence of chronic obstructive pulmonary disease (COPD) varies between countries and age groups but is estimated to be between 15 and 20% in the European adult populations over 40 years. COPD is accompanied with increased risk of multiple, chronic comorbidities. One of those chronic illnesses that shows a higher probability to coexist with COPD is cardiovascular disease.
Objective Assessment of hazards of COPD on the management and outcome of patients admitted to coronary care unit (CCU).
Patients and methods A case-control study was designed between September 2015 and March 2016, including 100 consecutive patients admitted to the CCU for more than 24 h in Rail Way Hospital in Cairo, Egypt. Two groups with equal number of cases were recruited in the study (COPD patients and non-COPD patients). All of them were admitted to the CCU for more than 24 h due to several cardiac emergencies. Follow-up and monitoring the management of either COPD or non-COPD patients in CCU was done.
Results Both groups were matched for age and sex. Several causes were the reason for admission to the CCU with no significant differences among both groups. No significant differences existed regarding cardiac interventions. More than 48% of the patients in the COPD group had needed to change their medications during their CCU stay which ranged from 1 to 3 agents. More patients in the COPD group required SpO2 monitoring inside the CCU (P |
---|---|
ISSN: | 0422-7638 2090-9950 |
DOI: | 10.4103/ejcdt.ejcdt_24_17 |